Thompson Siegel & Walmsley’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $69K | Hold |
|
|||||
2023
Q3 | $70K | Hold |
|
|||||
2023
Q2 | $69K | Sell |
|
|||||
2023
Q1 | $74K | Sell |
|
|||||
2022
Q4 | $144K | Sell |
|
|||||
2022
Q3 | $21.7M | Sell |
|
|||||
2022
Q2 | $30.5M | Sell |
|
|||||
2022
Q1 | $24.9M | Buy |
|
|||||
2021
Q4 | $28.9M | Sell |
|
|||||
2021
Q3 | $28.8M | Sell |
|
|||||
2021
Q2 | $49.4M | Sell |
|
|||||
2021
Q1 | $60M | Sell |
|
|||||
2020
Q4 | $56.4M | Sell |
|
|||||
2020
Q3 | $43.4M | Sell |
|
|||||
2020
Q2 | $53.7M | Sell |
|
|||||
2020
Q1 | $58M | Sell |
|
|||||
2019
Q4 | $73.8M | Sell |
|
|||||
2019
Q3 | $67.3M | Sell |
|
|||||
2019
Q2 | $67.5M | Buy |
|
|||||
2019
Q1 | $50.2M | Sell |
|
|||||
2018
Q4 | $49M | Sell |
|
|||||
2018
Q3 | $65.5M | Sell |
|
|||||
2018
Q2 | $63.3M | Buy |
|
|||||
2018
Q1 | $61M | Sell |
|
|||||
2017
Q4 | $86.8M | Sell |
|
|||||
2017
Q3 | $69.2M | Buy |
|
|||||
2017
Q2 | $75.4M | Buy |
|
|||||
2017
Q1 | $66.2M | Sell |
|
|||||
2016
Q4 | $74M | Sell |
|
|||||
2016
Q3 | $63.1M | Sell |
|
|||||
2016
Q2 | $60.1M | Buy |
|
|||||
2016
Q1 | $26.3M | Buy |
|
|||||
2015
Q4 | $716K | Sell |
|
|||||
2015
Q3 | $690K | Sell |
|
|||||
2015
Q2 | $1.76M | Sell |
|
|||||
2015
Q1 | $1.75M | Sell |
|
|||||
2014
Q4 | $1.85M | Sell |
|
|||||
2014
Q3 | $18.9M | Buy |
|
|||||
2014
Q2 | $22K | Sell |
|
|||||
2014
Q1 | $907K | Sell |
|
|||||
2013
Q4 | $1.4M | Sell |
|
|||||
2013
Q3 | $32.6M | Sell |
|
|||||
2013
Q2 | $38M | Buy |
|